Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

The First Newborn Screening Study of T-Cell Receptor Excision Circle and κ-Deleting Recombination Excision Circle for Severe Combined Immunodeficiency in Korea: A Pilot Study

국내 최초 T-Cell Receptor Excision Circle과 κ-Deleting Recombination Excision Circle 신생아 선별검사에 관한 연구

  • Son, Sohee (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Ji-Man (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Jong Min (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Sung, Sein (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Yi-Seoul (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Haejeong (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, BitA Reum (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Yeon Kyoung (Department of Pediatrics, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine) ;
  • Ko, Sun Young (Department of Pediatrics, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine) ;
  • Shin, Son Moon (Department of Pediatrics, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine) ;
  • Kim, Yae-Jean (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 손소희 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 강지만 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 김종민 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 성세인 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 김이슬 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 이해정 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 김빛아름 (성균관대학교 의과대학 삼성서울병원 소아청소년과) ;
  • 이연경 (단국대학교 의과대학 제일병원 소아청소년과) ;
  • 고선영 (단국대학교 의과대학 제일병원 소아청소년과) ;
  • 신손문 (단국대학교 의과대학 제일병원 소아청소년과) ;
  • 김예진 (성균관대학교 의과대학 삼성서울병원 소아청소년과)
  • Received : 2017.05.09
  • Accepted : 2017.06.23
  • Published : 2017.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Severe combined immunodeficiency (SCID) is the most serious form of primary immunodeficiency. Infants with SCID are susceptible to life-threatening infections. To establish newborn screening for SCID in Korea, we performed a screening test for T-cell receptor excision circle (TREC) and ${\kappa}$-deleting recombination excision circle (KREC) in neonates and investigated the awareness of SCID among their parents. Methods: Collections of dried blood spots from neonates and parent surveys were performed at the Samsung Medical Center and Cheil General Hospital & Women's Healthcare Center in Korea. The amplification crossing point (Cp) value <37.0 was defined as TREC/KRECpositive based on cutoff values from measuring multiplex real-time polymerase chain reaction. A Cp value >39.0 was defined as negative. Results: For TREC/KREC screening, 141 neonates were enrolled; 63 (44.7%) were male. One hundred forty neonates (99.3%) had positive TREC/KREC results at the time of the initial test; 82.3% and 75.9% were positive and 17.0% and 23.4% were weakly positive for TREC and KREC, respectively. In one neonate (0.7%), the initial TREC/KREC test result was negative. However, repeated tests obtained and confirmed a positive result. For an awareness survey, 168 parents were engaged. Only 2% of parents (3/168) knew that the newborn screening test for SCID had been introduced and performed in other countries. Eighty-four percent of parents (141/168) replied that nationwide newborn SCID screening should be performed in Korean newborns. Conclusions: In this study, newborn SCID screening was performed along with assessment of public awareness of the SCID test in Korea. The study results showed that newborn SCID screening can be readily applied for clinical use at a relatively low cost in Korea.

목적: 중증복합면역결핍증(severe combined immunodeficiency [SCID])은 일차면역결핍증 중 가장 심각한 형태의 질병이다. 국내에서 SCID 선별검사를 확립하기 위하여, 신생아에게 T-cell receptor excision circle (TREC)/${\kappa}$-deleting recombination excision circle (KREC) 선별검사를 시행하고, 부모에게 인식도를 조사하였다. 방법: 혈액 검체에서 TREC/KREC을 multiplex 실시간중합효소연쇄반응으로 분석하였다. 부모에게 설문조사를 실시하였다. 결과: 141명의 신생아가 선별검사에 참여하였고, 140명(99.3%)이 첫 검사에서 TREC/KREC 양성이었으며, 한 명(0.7%)은 처음에 음성이었으나, 추후 양성으로 확인되었다. 인식도 조사에는 84% (141/168)는 SCID 선별검사가 국내에서도 시행되어야 한다고 답변했다. 결론: 본 연구에서는 국내에서 처음으로 신생아 SCID 선별검사와 인식도 시행되었으며, SCID 선별검사가 국내 임상에 적용될 수 있을 것으로 보인다.

Keywords

References

  1. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508-16. https://doi.org/10.1056/NEJM199902183400703
  2. Brown L, Xu-Bayford J, Allwood Z, Slatter M, Cant A, Davies EG, et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 2011; 117:3243-6. https://doi.org/10.1182/blood-2010-08-300384
  3. Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med 2014;371:434-46. https://doi.org/10.1056/NEJMoa1401177
  4. Immune Deficiency Foundation (IDF). IDF SCID newborn screening campaign [Internet]. Towson: IDF; c2017 [cited 2017 Nov 7]. Available from: https://primaryimmune.org.
  5. GOV.UK. Population screening programmes [Internet]. GOV.UK.; 2017 [cited 2017 Nov 7]. Available from: https://www.gov.uk/topic/population-screening-programmes/newborn-blood-spot.
  6. van Zelm MC, van der Burg M, Langerak AW, van Dongen JJ. PID comes full circle: applications of V(D) J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front Immunol 2011;2:12.
  7. Borte S, von Dobeln U, Fasth A, Wang N, Janzi M, Winiarski J, et al. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012;119:2552-5. https://doi.org/10.1182/blood-2011-08-371021
  8. Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014;312:729-38. https://doi.org/10.1001/jama.2014.9132
  9. Bousfiha A, Jeddane L, Al-Herz W, Ailal F, Casanova JL, Chatila T, et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 2015;35: 727-38. https://doi.org/10.1007/s10875-015-0198-5
  10. Chien YH, Chiang SC, Chang KL, Yu HH, Lee WI, Tsai LP, et al. Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. J Formos Med Assoc 2015;114:12-6. https://doi.org/10.1016/j.jfma.2012.10.020
  11. Rhim JW, Kim KH, Kim DS, Kim BS, Kim JS, Kim CH, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci 2012;27:788-93. https://doi.org/10.3346/jkms.2012.27.7.788
  12. Centerwall WR, Chinnock RF, Pusavat A. Phenylketonuria: screening programs and testing methods. Am J Public Health Nations Health 1960;50:1667-77. https://doi.org/10.2105/AJPH.50.11.1667
  13. Puck JM. The case for newborn screening for severe combined immunodeficiency and related disorders. Ann N Y Acad Sci 2011;1246:108-17. https://doi.org/10.1111/j.1749-6632.2011.06346.x
  14. McGhee SA, Stiehm ER, McCabe ER. Potential costs and benefits of newborn screening for severe combined immunodeficiency. J Pediatr 2005;147:603-8. https://doi.org/10.1016/j.jpeds.2005.06.001
  15. Lee DH. Newborn screening of inherited metabolic disease in Korea. Korean J Pediatr 2006;49:1125-39. https://doi.org/10.3345/kjp.2006.49.11.1125

Cited by

  1. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center vol.38, pp.7, 2018, https://doi.org/10.1007/s10875-018-0542-7